ScreenerHero

BIOVIC-B Biovica International AB (publ)

STO · SE · Healthcare · Biotechnology · biovica.com
0.2920SEK-3.95%Mkt Cap: 8.15M $P/E: —

Biovica International AB (publ), a biotech company, develops and commercializes blood-based biomarker assays for oncologists monitor cancer progression in the European Union, the United States, and Asia. The company enga…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap8.15M USD
Enterprise Value4.13M USD
Revenue (TTM)1.43M USD
Gross Profit1.28M USD
Net Income (TTM)-6.68M USD
Revenue/Share0.05 SEK
Last Price0.2920 SEK
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees24
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.29
PEG—
EV/EBITDA-0.61
EV/Revenue2.89
P/S5.94
P/B1.33
EPS (TTM)-0.26
EPS (Forward)-1.04
52W Range
0.27006% of range0.6300
52W High0.6300 SEK
52W Low0.2700 SEK
Profitability
Gross Margin99.68%
Oper. Margin-505.71%
EBITDA Margin0.00%
Profit Margin-522.12%
ROE-80.92%
ROA-64.84%
Growth
Revenue Growth55.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.01M USD
CapEx (TTM)45.34K USD
FCF Margin-328.75%
FCF Yield-57.59%
Net Debt-4.36M USD
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity0.05
Current Ratio3.06
Quick Ratio2.95
Book Value/Sh0.23 SEK
Cash/Share0.18 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.6000 SEK
Upside (mean)+105.5%
Target Range0.6000 SEK – 0.6000 SEK
# Analysts1
Ownership
Shares Out.277.49M
Float166.60M
Insiders42.43%
Institutions18.81%
Technical
SMA 500.4175 (-30.1%)
SMA 2000.3860 (-24.4%)
Beta1.22
S&P 52W Chg16.45%
Avg Vol (30d)759.87K
Avg Vol (10d)435.87K
Technical Indicators
RSI (14)30.2
MACD-0.0283
MACD Signal-0.0320
MACD Hist.+0.0036
BB Upper0.3236 SEK
BB Middle0.3080 SEK
BB Lower0.2925 SEK
BB Width10.07%
ATR (14)0.0212 SEK
Vol Ratio (20d)1.21x